Dr Seau Tak Cheung

Consultant Dermatologist

BMedSci (Hons), MB ChB, FRCP

Professional Memberships

  • Fellow of the Royal College of Physicians
  • British Association of Dermatologists
  • British Society of Dermatological Surgery
  • British Medical Dermatology Society
  • European Academy of Dermatology and Venereology

Clinical Interests

  • General Dermatology, including acne, psoriasis,eczema
  • Skin cancer and skin surgery
  • Removing lumps and bumps
  • Mole checks
  • Excess sweating including botulinum toxin injections for axilla (underarms)
  • Hair and nails

Personal profile

Dr Seau Tak Cheung graduated from Dundee Medical School in 2000 where he also obtained a Pharmacology medical science degree.

Dr Cheung finished his general medical training in Birmingham. His Dermatology specialist training was undertaken in the West Midlands, which he completed in 2007 to become a Consultant Dermatologist. In 2015, he became a Fellow of the Royal College of Physicians (London). He is now based in London.

He manages a wide variety of general skin conditions. His subspeciality interest is skin cancer and has experience of developing a photodynamic therapy and an advanced dermatological surgery service. He has held several clinical leadership roles in NHS hospitals. These included Skin Cancer Lead and clinical Cancer Lead for the Hospital as well as Dermatology Clinical Director. 

Dr Cheung has also been extensively involved in dermatology clinical research, which included studies of new psoriasis, actinic keratosis and vitiligo treatments. In 2016, he was awarded the prestigious National Institute for Health Research (NIHR) Leading Commercial Principal Investigator Award. He also received earlier commendation from the same awarding Body. Furthermore, he has been the Dermatology co-lead of the NIHR West Midlands Local Clinical Research Network and was a member of the Dermatology National Speciality Group research committee. He remains part of the expert group assessing new studies.

His continued academic interest have led him to be involved in the publications of national audits of psoriasis and acne management as well as a dermatology representative of the NICE group that recently produced guidance into certain joint disease care. Furthermore, he is a member of a British Association of Dermatologists subcommittee. He has also been a clinical and educational supervisor for Specialist Dermatology trainees.

Year qualified: